Featured Research

from universities, journals, and other organizations

UC Riverside Study Indicates Mosquito Coils May Cause Cancer

Date:
September 8, 2003
Source:
University Of California - Riverside
Summary:
The mosquito coil made in some Asian countries that people often use to ward off mosquitoes may be releasing cancer-causing smoke, scientists at UC Riverside report in the journal Environmental Health Perspectives.

RIVERSIDE, Calif. -- The mosquito coil made in some Asian countries that people often use to ward off mosquitoes may be releasing cancer-causing smoke, scientists at UC Riverside report in the journal Environmental Health Perspectives.

The scientists – Bob Krieger, Travis Dinoff and Xiaofei Zhang of the department of entomology – sampled coils from Indonesia and Asian markets in Southern California and found that the contained "S-2" or octachlorodipropyl ether, banned for sale in the United States.

"It is very possible that the coils are exposing users to bischloromethyl ether, also called BCME, a potent lung carcinogen," said Krieger. "High exposure can occur if the coils are used overnight, as they often are."

Because of mosquito-borne diseases such as West Nile virus, the use of these mosquito coils may be on the increase. "These coils purchased in stores in the United States do not list S-2 as an ingredient," said Krieger. "This suggests that illegal, unregistered products are able to find their way into the American market."

For their research, the authors sampled more than 50 coils collected from Asia and California. "Next, we plan to measure levels of BCME in indoor environments where the coils are used," said Krieger. "We hope that epidemiologists will take an interest due to the number of people exposed and the potency of BCME."


Story Source:

The above story is based on materials provided by University Of California - Riverside. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - Riverside. "UC Riverside Study Indicates Mosquito Coils May Cause Cancer." ScienceDaily. ScienceDaily, 8 September 2003. <www.sciencedaily.com/releases/2003/09/030908072025.htm>.
University Of California - Riverside. (2003, September 8). UC Riverside Study Indicates Mosquito Coils May Cause Cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2003/09/030908072025.htm
University Of California - Riverside. "UC Riverside Study Indicates Mosquito Coils May Cause Cancer." ScienceDaily. www.sciencedaily.com/releases/2003/09/030908072025.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins